Correction: Real‑world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first‑ or second‑line treatment for hormone receptor–positive, HER2‑negative advanced or metastatic breast cancer

• 期刊论文

• 出版模式：

  开放获取

• 发表日期：

  2025年6月23日

• Tetsuhiro Yoshinami,
• Yuko Takano,
• Yukinori Ozaki,
• Yukiko Kajiwara,
• Mitsugu Yamamoto,
• Ken-ichi Watanabe,
• Masami Tsukabe,
• Fumie Fujisawa,
• Shigenori E. Nagai,
• Nobuhiro Shibata,
• Chiya Oshiro,
• Hiroko Bando,
• Nobuyuki Tsunoda,
• Kazuhiko Yamagami,
• Kei Koizumi,
• Masahiro Takada,
• Naoko Toriguchi,
• Nobuyuki Sekine,
• Tsutomu Kawaguchi,
• Shigehira Saji,
• Yasuaki Sagara,
• Satoshi Morita,
• Norikazu Masuda